An international study, the first of its kind to use an online survey to capture the long-term effects of Electroconvulsive ...
Zacks Small Cap Research on MSN
CYCN: Engineering a reset; initiating coverage of Cyclerion Therapeutics
By David Bautz, PhD NASDAQ:CYCN READ THE FULL CYCN RESEARCH REPORT Initiating Coverage We are initiating coverage of ...
When asked open questions about the effects of electroconvulsive therapy, 51% reported negative effects only, 3% reported ...
Spin-out Merge Labs aims to rival Elon Musk’s brain-chip company Neuralink. But researchers say the technology is still at an ...
14hon MSN
A 'window to the brain': Chip tracks glioblastoma treatment response using tumor vesicles in blood
Technology created at the University of Queensland could improve the odds of surviving brain cancer and change how we treat a range of neurological conditions. Dr. Richard Lobb and Dr. Zhen Zhang from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results